{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:31:21Z","timestamp":1791228681098,"version":"4.1.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>On antigen binding by the B-cell receptor (BCR), B cells up-regulate protein expression of the key downstream signaling molecule Bruton tyrosine kinase (Btk), but the effects of Btk up-regulation on B-cell function are unknown. Here, we show that transgenic mice overexpressing Btk specifically in B cells spontaneously formed germinal centers and manifested increased plasma cell numbers, leading to antinuclear autoantibody production and systemic lupus erythematosus (SLE)\u2013like autoimmune pathology affecting kidneys, lungs, and salivary glands. Autoimmunity was fully dependent on Btk kinase activity, because Btk inhibitor treatment (PCI-32765) could normalize B-cell activation and differentiation, and because autoantibodies were absent in Btk transgenic mice overexpressing a kinase inactive Btk mutant. B cells overexpressing wild-type Btk were selectively hyperresponsive to BCR stimulation and showed enhanced Ca2+ influx, nuclear factor (NF)\u2013\u03baB activation, resistance to Fas-mediated apoptosis, and defective elimination of selfreactive B cells in vivo. These findings unravel a crucial role for Btk in setting the threshold for B-cell activation and counterselection of autoreactive B cells, making Btk an attractive therapeutic target in systemic autoimmune disease such as SLE. The finding of in vivo pathology associated with Btk overexpression may have important implications for the development of gene therapy strategies for X-linked agammaglobulinemia, the immunodeficiency associated with mutations in BTK.<\/jats:p>","DOI":"10.1182\/blood-2011-12-397919","type":"journal-article","created":{"date-parts":[[2012,3,3]],"date-time":"2012-03-03T17:59:06Z","timestamp":1330797546000},"page":"3744-3756","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":198,"title":["Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice"],"prefix":"10.1182","volume":"119","author":[{"given":"Laurens P.","family":"Kil","sequence":"first","affiliation":[{"name":"Departments of Pulmonary Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein J. W.","family":"de Bruijn","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno","family":"van Nimwegen","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odilia B. J.","family":"Corneth","sequence":"additional","affiliation":[{"name":"Rheumatology, and"},{"name":"Immunology, Erasmus Medical Center, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Piet","family":"van Hamburg","sequence":"additional","affiliation":[{"name":"Rheumatology, and"},{"name":"Immunology, Erasmus Medical Center, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma M.","family":"Dingjan","sequence":"additional","affiliation":[{"name":"Immunology, Erasmus Medical Center, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Thaiss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology, University Hospital Hamburg-Eppendorf, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[{"name":"Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Elewaut","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Delsing","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme, Oss, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Fokko","family":"van Loo","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi W.","family":"Hendriks","sequence":"additional","affiliation":[{"name":"Departments of Pulmonary Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111808160177500_B1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.coi.2009.08.005","article-title":"Activating systemic autoimmunity: B's, T's, and tolls.","volume":"21","author":"Shlomchik","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2019111808160177500_B2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease.","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"issue":"3","key":"2019111808160177500_B3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2008.07.047","article-title":"Altered B cell receptor signaling in human systemic lupus erythematosus.","volume":"8","author":"Jenks","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"6","key":"2019111808160177500_B4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.coi.2010.09.002","article-title":"Recent findings on genetics of systemic autoimmune diseases.","volume":"22","author":"Delgado-Vega","year":"2010","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"2019111808160177500_B5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrrheum.2010.63","article-title":"Genetics of SLE: evidence from mouse models.","volume":"6","author":"Morel","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"2019111808160177500_B6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2010.05.006","article-title":"B-cell tolerance breakdown in Sjogren's syndrome: focus on BAFF.","volume":"9","author":"Varin","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"10","key":"2019111808160177500_B7","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.191.10.1745","article-title":"Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.","volume":"191","author":"Petro","year":"2000","journal-title":"J Exp Med"},{"issue":"10","key":"2019111808160177500_B8","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.191.10.1735","article-title":"Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation.","volume":"191","author":"Bajpai","year":"2000","journal-title":"J Exp Med"},{"issue":"6","key":"2019111808160177500_B9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2006.04.005","article-title":"Canonical NF-kappaB activity, dispensable for B-cell development, replaces BAFF-receptor signals and promotes B-cell proliferation upon activation.","volume":"24","author":"Sasaki","year":"2006","journal-title":"Immunity"},{"key":"2019111808160177500_B10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts.","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2019111808160177500_B11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/1074-7613(95)90114-0","article-title":"Defective B-cell development and function in Btk-deficient mice.","volume":"3","author":"Khan","year":"1995","journal-title":"Immunity"},{"issue":"18","key":"2019111808160177500_B12","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1002\/j.1460-2075.1996.tb00867.x","article-title":"Inactivation of Btk by insertion of lacZ reveals defects in B-cell development only past the pre-B cell stage.","volume":"15","author":"Hendriks","year":"1996","journal-title":"EMBO J"},{"issue":"6","key":"2019111808160177500_B13","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.4049\/jimmunol.168.6.2695","article-title":"Impaired precursor B-cell differentiation in Bruton's tyrosine kinase-deficient mice.","volume":"168","author":"Middendorp","year":"2002","journal-title":"J Immunol"},{"issue":"8","key":"2019111808160177500_B14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/14728222.2011.585971","article-title":"Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man.","volume":"15","author":"Hendriks","year":"2011","journal-title":"Expert Opin Ther Targets"},{"issue":"24","key":"2019111808160177500_B15","doi-asserted-by":"crossref","first-page":"13152","DOI":"10.1073\/pnas.94.24.13152","article-title":"Btk dosage determines sensitivity to B cell antigen receptor cross-linking.","volume":"94","author":"Satterthwaite","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808160177500_B16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1073\/pnas.94.2.610","article-title":"Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region.","volume":"94","author":"Drabek","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111808160177500_B17","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1073\/pnas.050583597","article-title":"Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.","volume":"97","author":"Nisitani","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111808160177500_B18","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/blood-2007-10-121137","article-title":"Proteasome-dependent autoregulation of Bruton tyrosine kinase (Btk) promoter via NF-kappaB.","volume":"111","author":"Yu","year":"2008","journal-title":"Blood"},{"issue":"20","key":"2019111808160177500_B19","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1093\/emboj\/20.20.5692","article-title":"PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization.","volume":"20","author":"Kang","year":"2001","journal-title":"EMBO J"},{"issue":"10","key":"2019111808160177500_B20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/ni1001-939","article-title":"Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein.","volume":"2","author":"Liu","year":"2001","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111808160177500_B21","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.1074\/jbc.M108537200","article-title":"Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx.","volume":"277","author":"Vargas","year":"2002","journal-title":"J Biol Chem"},{"issue":"26","key":"2019111808160177500_B22","doi-asserted-by":"crossref","first-page":"18201","DOI":"10.1074\/jbc.M603090200","article-title":"Regulation of Bruton tyrosine kinase by the peptidylprolyl isomerase Pin1.","volume":"281","author":"Yu","year":"2006","journal-title":"J Biol Chem"},{"issue":"5","key":"2019111808160177500_B23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.immuni.2010.11.010","article-title":"MicroRNAs prevent the generation of autoreactive antibodies.","volume":"33","author":"Belver","year":"2010","journal-title":"Immunity"},{"issue":"7277","key":"2019111808160177500_B24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"23","key":"2019111808160177500_B25","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton's tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111808160177500_B26","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.4049\/jimmunol.162.11.6526","article-title":"Early arrest in B-cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.","volume":"162","author":"Maas","year":"1999","journal-title":"J Immunol"},{"issue":"18","key":"2019111808160177500_B27","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1093\/emboj\/17.18.5309","article-title":"Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.","volume":"17","author":"Dingjan","year":"1998","journal-title":"EMBO J"},{"issue":"9","key":"2019111808160177500_B28","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/eji.201040521","article-title":"Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells.","volume":"40","author":"Kersseboom","year":"2010","journal-title":"Eur J Immunol"},{"issue":"11","key":"2019111808160177500_B29","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.4049\/jimmunol.171.11.5988","article-title":"Function of Bruton's tyrosine kinase during B-cell development is partially independent of its catalytic activity.","volume":"171","author":"Middendorp","year":"2003","journal-title":"J Immunol"},{"issue":"7","key":"2019111808160177500_B30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni1480","article-title":"Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.","volume":"8","author":"Hoffmann","year":"2007","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111808160177500_B31","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1084\/jem.20090410","article-title":"Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice.","volume":"206","author":"GeurtsvanKessel","year":"2009","journal-title":"J Exp Med"},{"issue":"10","key":"2019111808160177500_B32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2009.2","article-title":"Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice.","volume":"75","author":"Benndorf","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"2019111808160177500_B33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cmdc.200600221","article-title":"Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase.","volume":"2","author":"Pan","year":"2007","journal-title":"ChemMedChem"},{"issue":"5","key":"2019111808160177500_B34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/BOR.0b013e32832efff1","article-title":"Pathogenesis of kidney disease in systemic lupus erythematosus.","volume":"21","author":"Bagavant","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"2019111808160177500_B35","first-page":"971","article-title":"Validation of a new screening strategy for anti-extractable nuclear antigen antibodies.","volume":"27","author":"Van Praet","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"2019111808160177500_B36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(03)00297-8","article-title":"BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity.","volume":"19","author":"Saito","year":"2003","journal-title":"Immunity"},{"issue":"1","key":"2019111808160177500_B37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2004-07-2708","article-title":"Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity.","volume":"105","author":"Middendorp","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2019111808160177500_B38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.icb.7100142","article-title":"B cells flying solo.","volume":"86","author":"Groom","year":"2008","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"2019111808160177500_B39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter.","volume":"143","author":"Victora","year":"2010","journal-title":"Cell"},{"issue":"3","key":"2019111808160177500_B40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B-cell development and survival in the absence of normal B cell receptor signals.","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"issue":"3","key":"2019111808160177500_B41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ni1036","article-title":"B cell receptor signal strength determines B cell fate.","volume":"5","author":"Casola","year":"2004","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111808160177500_B42","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity.","volume":"165","author":"Sato","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"2019111808160177500_B43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","article-title":"Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.","volume":"13","author":"Bolland","year":"2000","journal-title":"Immunity"},{"issue":"7","key":"2019111808160177500_B44","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.4049\/jimmunol.0902711","article-title":"CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.","volume":"184","author":"Jellusova","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"2019111808160177500_B45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ng0693-124","article-title":"Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.","volume":"4","author":"Tsui","year":"1993","journal-title":"Nat Genet"},{"issue":"1","key":"2019111808160177500_B46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2007.04.016","article-title":"B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity.","volume":"27","author":"Pao","year":"2007","journal-title":"Immunity"},{"issue":"2","key":"2019111808160177500_B47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(95)90171-X","article-title":"Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease.","volume":"83","author":"Hibbs","year":"1995","journal-title":"Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/16\/3744\/1476473\/zh801612003744.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/16\/3744\/1476473\/zh801612003744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T17:46:50Z","timestamp":1687283210000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/16\/3744\/29958\/Btk-levels-set-the-threshold-for-Bcell-activation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,19]]},"references-count":47,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2012,4,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-12-397919","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,19]]}}}